Exhibit Hall Navigation
Immuno-Oncology: Taking Immunotherapies to the Next Level
105AB, Level 100
EVP, Oncology Practice Head at
Cello Health BioConsulting (Previously Defined Health)
Chief Operating Officer at
Senior Biotechnology Analyst at
New Enterprise Associates (NEA)
Abeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics at
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center,
Associate Vice President at
Merck & Co., Inc.
The BPCIA is Turning Ten: What's Next for Biosimilars?
118C, Level 100
Akin Gump Strauss Hauer & Feld LLP
Vice President & Assistant General Counsel at
Vice President of Intellectual Property, North America at
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Event App Powered by Zerista